Microsoft and LG Renew Patent Cross License Agreement
Microsoft Corp. and LG Electronics Inc. have announced in REDMOND, Washington. on Aug. 19, 2018 that they have entered into a patent cross-license agreement to further the development of the company’s current and future product lines. This agreement between Microsoft and LG Electronics provides overall coverage under patent portfolio for LG’s tablets, mobile phones and […]
Microsoft Cross Licensing
Microsoft grants licenses to companies under fair and reasonable terms. It is important for the company claiming license to adhere with the Microsoft’s IP licensing policy. The process for granting license is non-exclusive and is based on “commercially reasonable” terms i.e. terms under which other technology industry license is granted. Microsoft entered into more than 1200 licensing […]
Steering Towards Success, The Bishop’s Way
IP (Patent) Licensing and Commercialization Case Study: Bishop Steering Intellectual Property can be understood as creations of the mind such as inventions, expressions in the form of literary, artistic or other works of expression, symbols, names and images, etc. used in commerce. It can further be divided into Industrial Property or Copyright.[1] Patent as a part […]
Steering Towards Success, The Bishop’s Way
IP (Patent) Licensing and Commercialization Case Study: Bishop Steering Intellectual Property can be understood as creations of the mind such as inventions, expressions in the form of literary, artistic or other works of expression, symbols, names and images, etc. used in commerce. It can further be divided into Industrial Property or Copyright.[1] Patent as a […]
Licensing Agreement for Multiple Pediatric-focused Products between Lupin and MonoSol Rx
Reportedly, Lupin Pharmaceutical Inc.(LPI,US subsidiary of pharma major Lupin Limited) and MonoSol Rx, a specialty pharmaceutical company have entered into a strategic licensing agreement (OCT-2016) wherein Lupin would develop multiple pediatric products utilizing MonoSol Rx’s patented PharmFilm® drug delivery technology. Lupin Limited is an innovation led transnational pharmaceutical company which develops and offers a wide […]
Licensing Agreement for Multiple Pediatric-focused Products between Lupin and MonoSol Rx
Reportedly, Lupin Pharmaceutical Inc.(LPI,US subsidiary of pharma major Lupin Limited) and MonoSol Rx, a specialty pharmaceutical company have entered into a strategic licensing agreement (OCT-2016) wherein Lupin would develop multiple pediatric products utilizing MonoSol Rx’s patented PharmFilm® drug delivery technology. Lupin Limited is an innovation led transnational pharmaceutical company which develops and offers a wide […]
Amazon improves foothold in India: signs content licensing deal with T-series
E-commerce is growing widespread day by day in Indian market. It has become a current day reality from a buzzword, transformed the way business is done, transformed the way people transact and more specifically, has totally transformed the game for the Indian economy. Nowadays online market space is available for almost everything; you just think […]
Medicines Patent Pool’s Voluntary Licensing; Unique in its efforts to better treat the Infection
Efforts of Medicines Patent Pool (hereinafter referred to as “MPP”); a United Nations backed public health organisation, founded in July 2010, and based in Geneva, Switzerland are praiseworthy. The lives of millions of people in poor developing countries depend on access to affordable medicines. However, unfortunately most of the world’s population does not receive the […]
Medicines Patent Pool’s Voluntary Licensing; Unique in its efforts to better treat the Infection
Efforts of Medicines Patent Pool (hereinafter referred to as “MPP”); a United Nations backed public health organisation, founded in July 2010, and based in Geneva, Switzerland are praiseworthy. The lives of millions of people in poor developing countries depend on access to affordable medicines. However, unfortunately most of the world’s population does not receive the […]
IIPRD assists Venus Remedies in Successful Technology Out-licensing of Potentox to Adcock, South Africa
Venus Remedies Ltd. has successfully out-licensed its new generation antibiotic drug Potentox to Adcock Ingram Ltd. in South Africa earlier this year. Potentox is a Fixed-Dose Combination (FDC) of Cefepime Hydrochloride & Amikacin Sulphate developed by Venus Remedies Ltd., indicated for the treatment of Nosocomial Pneumonia & Febrile Neutropenia and available as dry powder for […]